文献速递瓣膜病与结构性心脏病心力衰竭与心肌病

单纯经食管超声引导二尖瓣缘对缘修复的中期结局

[Midterm outcomes of transcatheter edge-to-edge repair mitral valve guided solely by transesophageal echocardiography].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2026-01-01

本研究回顾性纳入46例二尖瓣反流患者,均在单纯经食管超声心动图(TEE)引导下完成经导管二尖瓣缘对缘修复术(MV-TEER)。中位随访15.80个月,术后1年因心力衰竭再住院率为20%,1例死于恶性心律失常,无再次二尖瓣干预;左心室收缩末期内径、容积及射血分数和6分钟步行距离均较术前显著改善。初步证实该术式安全有效,中期预后良好。

要点

  • 46例患者均在单纯TEE引导下成功完成MV-TEER。
  • 术后1年因心衰再住院率20%,1例死于恶性心律失常,无再次干预。
  • 术后1年左心室重构、射血分数及6分钟步行距离均显著改善。

核心结论

  • 初步证实单纯TEE引导下MV-TEER安全、有效,患者中期预后良好。

研究设计与样本

  • 回顾性纳入2023年1月至2024年1月于郑州大学华中阜外医院接受单纯TEE引导下MV-TEER的二尖瓣反流患者46例。
  • 术后1、3、6及12个月随访超声心动图、6分钟步行试验、NYHA心功能分级及二尖瓣反流程度,记录心衰住院、二尖瓣再次干预及全因死亡。
  • 采用Kaplan-Meier法计算因心力衰竭再住院率的累积发生率。

主要发现

  • 46例患者均成功在单纯TEE引导下实施MV-TEER。
  • 中位随访15.80(12.63,20.64)个月,术后1年因心力衰竭再住院率为20%。
  • 因恶性心律失常死亡1例,无二尖瓣再次干预者。
  • 术后1年左心室收缩末期内径从(47.17±11.31)mm降至(39.71±7.44)mm(P<0.05)。
  • 术后1年左心室收缩末期容积从(87.02±20.63)ml降至(72.18±17.30)ml(P<0.05),左心室射血分数从(44.98±11.78)%改善至(51.84±10.03)%(P<0.05)。

临床怎么用

  • 对于二尖瓣反流患者,可考虑在单纯TEE引导下实施MV-TEER,无需额外影像引导。
  • 术后应规律随访超声心动图、心功能及运动耐量,监测心衰再住院及恶性心律失常。

局限性

  • 本研究为单中心回顾性研究,样本量46例,结论需更大规模前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To preliminarily evaluate the efficacy and safety of transcatheter edge-to-edge repair of the mitral valve (MV-TEER) guided solely by transesophageal echocardiography (TEE). Methods: A total of 46 patients with mitral regurgitation who underwent MV-TEER guided solely by transesophageal echocardiography (TEE) at Central China Fuwai Hospital of Zhengzhou University from January 2023 to January 2024 were retrospectively enrolled. Follow-up was performed at 1, 3, 6, and 12 months after the procedure, including echocardiography, 6-minute walk test, New York Heart Association (NYHA) functional classification, and grading of mitral regurgitation severity. Hospitalization for heart failure, repeat mitral valve intervention, and all-cause mortality were recorded. The cumulative incidence of rehospitalization for heart failure was estimated using the Kaplan-Meier method. Results: The median age of the enrolled patients was 67.5 (59.0, 73.0) years, and 29 patients (63%) were male. MV-TEER was successfully performed under sole TEE guidance in all 46 patients. The median follow-up duration was 15.80 (12.63, 20.64) months. The 1-year rehospitalization rate for heart failure was 20%, and 1 patient died of malignant arrhythmia. There was no repeat mitral valve intervention. At 1 year after the procedure, the left ventricular end-systolic diameter decreased significantly from (47.17±11.31) mm to (39.71±7.44) mm (P<0.05). The left ventricular end-systolic volume decreased from (87.02±20.63) ml to (72.18±17.30) ml (P<0.05), and the left ventricular ejection fraction improved from (44.98±11.78)% to (51.84±10.03)% (P<0.05). Five patients had mitral regurgitation grade 3+, while the remaining patients had grade less than 3+. Three patients were in NYHA functional class Ⅲ, 23 in class Ⅱ, and 19 in class Ⅰ. The 6-minute walk distance improved significantly from (298±78) m to (375±70) m (P<0.05). Conclusion: It is preliminarily demonstrated that MV-TEER guided solely by TEE is safe and effective, and patients have favorable midterm outcomes. 目的: 初步探讨单纯经食管超声心动图(TEE)引导下经导管二尖瓣缘对缘修复术(MV-TEER)的有效性、安全性。 方法: 选取2023年1月至2024年1月于郑州大学华中阜外医院接受单纯TEE引导下MV-TEER的二尖瓣反流患者46例。术后1、3、6及12个月进行门诊随访,复查超声心动图、6分钟步行试验、纽约心脏协会心功能分级、二尖瓣反流程度分级等,记录因心力衰竭住院、二尖瓣再次干预及全因死亡发生情况。采用Kaplan-Meier法计算因心力衰竭再住院率的累积发生率。 结果: 入选患者年龄为67.5(59.0,73.0)岁,其中男性29例(63%)。46例患者均在单纯TEE引导下成功实施MV-TEER。随访时间为15.80(12.63,20.64)个月,术后1年因心力衰竭再住院率为20%;因恶性心律失常死亡1例,无二尖瓣再次干预者。术后1年,患者的左心室收缩末期内径从术前(47.17±11.31)mm降至(39.71±7.44)mm(P<0.05),同时左心室收缩末期容积[(72.18±17.30)ml比(87.02±20.63)ml,P<0.05]以及左心室射血分数[(51.84±10.03)%比(44.98±11.78)%,P<0.05]均较术前改善;二尖瓣反流程度为3+者为5例,其余患者均在3+以下;纽约心脏协会心功能Ⅲ级者3例,Ⅱ级23例,Ⅰ级19例;6分钟步行距离较术前改善[(375±70)m比(298±78)m,P<0.05]。 结论: 初步证实单纯TEE引导下MV-TEER安全、有效,患者中期预后良好。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Xing WZ, Han Y, Zhang YH, et al. [Midterm outcomes of transcatheter edge-to-edge repair mitral valve guided solely by transesophageal echocardiography]. Zhonghua Xin Xue Guan Bing Za Zhi. 2026. PMID: 42907226. doi:10.3760/cma.j.cn112148-20260901-00550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。